You have read all your free articles, to continue reading subscribe to read the rest of this content.
The molecular diagnostics firm Elypta announced that it has been granted a patent by the United States Patent and Trademark Office for its novel liquid biopsy method for cancer diagnostics. The patent concerns a method for screening for renal cell carcinoma, the most common form of kidney cancer,Already a subscriber…
Orexo has announced that the US Patent and Trademark Office has issued an additional patent for ZUBSOLV, Orexo’s sublingual buprenorphine and naloxone tablet (CII) for the treatment of opioid use disorder. The new patent, US Patent No. 10,874,661, expires in September 2032 and further strengtheAlready a subscriber Login You have…
BioInvent International has announced that it has been granted a US patent for its antibody and concomitant target discovery technology F.I.R.S.T. The F.I.R.S.T. technology is a novel discovery method which allows for antibodies and disease targets to be identified simultaneously. BioInvent has uAlready a subscriber Login You have read all…
Genmab, Janssen and MorphoSys have agreed to end the patent infringement lawsuit launched by MorphoSys AG relating to DARZALEX. On January 25, 2019, the U.S. District Court of the District of Delaware ruled that all three patents that MorphoSys had asserted against Genmab and Janssen Biotech, IncAlready a subscriber Login…
